Kioxia Holdings Corp.
Kioxia Holdings Corp. (285A.T) Financial Performance & Income Statement Overview
Explore the financials of Kioxia Holdings Corp. (285A.T), including yearly and quarterly data on income, cash flow, and balance sheets.
Kioxia Holdings Corp. (285A.T) Income Statement & Financial Overview
View the income breakdown for Kioxia Holdings Corp. 285A.T across both annual and quarterly reports.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $347.09B | $449.96B | $480.91B | $428.50B |
| Cost of Revenue | $283.08B | $297.58B | $284.46B | $271.90B |
| Gross Profit | $64.02B | $152.37B | $196.45B | $156.59B |
| Gross Profit Ratio | $0.18 | $0.34 | $0.41 | $0.37 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $30.44B | $34.78B | $31.63B | $31.001B |
| Operating Expenses | $30.44B | $34.78B | $31.63B | $31.001B |
| Total Costs & Expenses | $313.52B | $332.36B | -$316.09B | -$302.91B |
| Interest Income | $1.14B | $3.04B | $3.77B | $199.00M |
| Interest Expense | $23.43B | $19.33B | $20.82B | $26.19B |
| Depreciation & Amortization | $77.51B | $77.11B | $79.19B | $78.49B |
| EBITDA | $115.80B | $202.86B | $248.99B | $204.55B |
| EBITDA Ratio | $0.33 | $0.45 | $0.52 | $0.48 |
| Operating Income | $33.58B | $117.60B | $164.82B | $125.59B |
| Operating Income Ratio | $0.10 | $0.26 | $0.34 | $0.29 |
| Other Income/Expenses (Net) | -$18.72B | -$11.17B | -$15.84B | -$25.73B |
| Income Before Tax | $14.86B | $106.42B | $148.98B | $99.87B |
| Income Before Tax Ratio | $0.04 | $0.24 | $0.31 | $0.23 |
| Income Tax Expense | -$5.20B | $30.61B | $42.95B | $29.99B |
| Net Income | $20.27B | $76.07B | $106.22B | $69.76B |
| Net Income Ratio | $0.06 | $0.17 | $0.22 | $0.16 |
| EPS | $38.70 | $141.11 | $197.05 | $129.41 |
| Diluted EPS | $38.70 | $141.11 | $197.05 | $129.41 |
| Weighted Avg Shares Outstanding | $523.72M | $539.06M | $539.06M | $539.06M |
| Weighted Avg Shares Outstanding (Diluted) | $523.72M | $539.06M | $539.06M | $539.06M |
Financial performance has remained strong, with revenue growing from $428.50B in Q1 2024 to $347.09B in Q4 2024. Gross profit continued to perform well, with margins at 18% in the latest quarter. Operating income reached $33.58B in Q4 2024, holding a steady 10% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $115.80B. Net income dropped to $20.27B, keeping EPS at $38.70. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan